Navigation Links
Tarix Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Study of TXA127 Following Autologous Peripheral Blood Stem Cell Transplant
Date:2/23/2011

usion of CD34+ cells. The study is expected to enroll a total of 74 patients at eight leading U.S. medical centers. For more information, please visit http://clinicaltrials.gov/ct2/show/NCT01121120?term=tarix&rank=2.

TXA127 will also be evaluated in two clinical trials in cord blood transplantation. One conducted at M D Anderson will involve adult patients, while the other at Duke University, will enroll pediatric patients.

About Tarix Pharmaceuticals

Tarix Pharmaceuticals is a clinical stage biopharmaceutical company developing peptide drugs to address significant unmet medical needs. The Company's lead product, TXA127, is a pharmaceutical formulation of the naturally occurring peptide, Angiotensin (1-7). TXA127 is currently in a Phase II clinical trial for the treatment and prevention of thrombocytopenia (reduced platelet count) associated with cancer chemotherapy, and a Phase II trial for peripheral blood stem cell engraftment. Tarix is preparing additional clinical trials with TXA127 in acute respiratory distress syndrome (ARDS), cord blood stem cell engraftment, and myelodysplastic syndrome (MDS). TXA127 is also being developed, under grants from the US government, as a treatment for radiation exposure.

Tarix's second product, PanCyte, is a synthetic, long-acting analogue of Angiotensin (1-7). PanCyte is in pre-clinical development focused on chemotherapy-induced thrombocytopenia and neutropenia, as well as combination treatment with low dose erythropoietin in chemotherapy-induced anemia.


'/>"/>
SOURCE Tarix Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Components of Extraneous Virus Detected in Rotarix Vaccine; No Known Safety Risk
2. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
3. New Data Published in The Lancet Show GSKs ROTARIX(R) Offers Protection Against the Most Common Circulating Rotavirus Types
4. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
5. Idenix Pharmaceuticals to Present at an Upcoming Investor Conference
6. Onyx Pharmaceuticals Reports Full Year and Fourth Quarter 2010 Financial Results
7. Avanir Pharmaceuticals to Present at Three Conferences in March
8. MAP Pharmaceuticals to Present at Upcoming Investor Conferences
9. Isis Pharmaceuticals Reports That Its Selective CRP Inhibitor Demonstrated Activity in a Phase 1 Study
10. Isis Pharmaceuticals to Present at the 2011 Citi Global Healthcare Conference
11. Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014 /PRNewswire-iReach/ -- Inc. magazine ... the third straight year, No. 349 in Health ... ranking of the nation,s fastest-growing private companies. The ... most important segment of the economy—America,s independent entrepreneurs. ... Pizza, LinkedIn, Zillow, and many other well-known names ...
(Date:8/21/2014)... Aug. 21, 2014 /PRNewswire-iReach/ -- ScriptPro has been ... under its Common Security Framework (CSF). According to ... Privacy Manager, "We appreciate this rigorous, top-to-bottom audit. ... that this certification signifies. Our business partners need ... THE CSF CERTIFICATION PROCESS: ScriptPro,s internal security processes ...
(Date:8/21/2014)... 2014  Zacks.com announces the list of stocks featured in ... discuss the latest news and events impacting stocks and the ... (NYSE: HPQ - Free Report ), IBM (NYSE: ... SB - Free Report ), GlaxoSmithKline plc (NYSE: GSK ... FI - Free Report ). Today, Zacks is ...
Breaking Medicine Technology:Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3ScriptPro Achieves HITRUST Certification 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 4The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 5The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 6The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 7The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 8The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 9The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 10The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 11
... HARLEYSVILLE, Pa. and LUDWIGSHAFEN, Germany, Oct. 20, 2011 ... the development of future film coating systems using Kollicoat® ... Colorcon has developed a pre-formulated additive ... enables efficient preparation and application of this polymer in ...
... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... management to discuss third quarter 2011 financial results, as well ... 2011, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). ... will be released earlier that day. Interested parties ...
Cached Medicine Technology:Colorcon and BASF Announce Collaboration to Develop Film Coating Applications Using Kollicoat® Smartseal 30 D 2
(Date:8/21/2014)... 2014Popular fiction that normalizes and glamorizes violence against women, ... associated with a greater risk of potentially harmful health ... study are presented in the article " Fiction or ... Adolescent and Young Adult Females ," published in ... Mary Ann Liebert, Inc., publishers . The article ...
(Date:8/21/2014)... Individuals with schizophrenia often have trouble engaging in ... new study from San Francisco State University suggests the ... of effort required to complete tasks. , The research, ... Journal of Abnormal Psychology , can assist health ... and help those patients function normally by breaking up ...
(Date:8/21/2014)... Entries are now open for the ... national awards program totally dedicated to recognizing excellence in ... leadership. The entry deadline is Oct. 17. , The ... the first and only national magazine entirely devoted to ... “We launched the HREI Insights Awards program last year ...
(Date:8/21/2014)... 2014 Recently it came to the ... located in Massachusetts has made public claims on August ... patient verification system in the Massachusetts cannabis industry. While ... our growing and compassionate industry we must set the ... are inaccurate. , MarijuanaDoctors.com has actually been providing ...
(Date:8/21/2014)... HealthDay Reporter THURSDAY, Aug. 21, 2014 ... respiratory syncytial virus (RSV), a leading cause of pneumonia in ... in being able to treat human RSV infections -- the ... to influenza virus," said study author Dr. John DeVincenzo, a ... Medicine in Memphis. "There is no current treatment ...
Breaking Medicine News(10 mins):Health News:Women's health and Fifty Shades: Increased risks for young adult readers? 2Health News:Difficulty assessing effort drives motivation deficits in schizophrenia, study finds 2Health News:Entries Open for 2014 HREI Insights Awards™ 2Health News:Entries Open for 2014 HREI Insights Awards™ 3Health News:Entries Open for 2014 HREI Insights Awards™ 4Health News:MarijuanaDoctors.com Responds to Massachusetts Company's Claim 2Health News:New Drug May Fight Serious Respiratory Virus in Infants 2Health News:New Drug May Fight Serious Respiratory Virus in Infants 3
... who undergo heart surgery fare better if they receive ... ,Investigators say that children who received reconstituted ... cells and plasma -- tended to accumulate less fluid, ... the study, researchers compared results for 200 infants who ...
... the brain using the CyberKnife frameless radiosurgery can successfully ... CyberKnife is a non-invasive robotic radiosurgical device that can ... uses a robotic arm, controlled by a computer, that ... tumor site. ,During the study researchers examined ...
... are obese when they are diagnosed with early-stage breast cancer ... women of normal weight.// ,Studies in the past have ... development, and has also shown to have contradictory results about ... latest study researchers say, they have demonstrated a significant association ...
... is an often disabling condition that affects primarily women. ... cannot be overcome with rest and often worsens with ... and there are no diagnostic tests or cures. A ... are at increased risk for developing chronic fatigue later ...
... in restoring sudden onset hearing loss. Researchers say sudden hearing ... of the sudden hearing loss can be identified in only ... includes viral and bacterial diseases, and metabolic, neurologic and immunologic ... which case there is no known cause. ,Previous research ...
... that affects more than 80 percent of teenagers and up ... cited // as a source of acne, these claims have ... this study. Each participant had at least one academic examination ... sources of stress for students. Stress levels were recorded using ...
Cached Medicine News:
...
...
Bimanual I&A Cannulas. Curved 45 with a .51mm open-end irrigation port. Facilitates removal of cortical debris between 10-2 o'clock. .80mm x 17.0mm...
...
Medicine Products: